eli lilly new glp 1 Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds US approves new oral weight-loss

For GLP-1 medications specifically, the advertised prices are significant

doi: 10.1186/s12902-023-01442-y

Although GIP only stimulates glucagon secretion under hypo- and euglycaemic conditions in healthy individuals (57), its glucagonotropic effect is exaggerated in T2D patients during hyperglycaemia (58)

For additional perspective, heres a list of more studies that show the same: A potential link between liraglutide and thyroid cancer (along with pancreatic and gallbladder problems as well) (3) Study highlighting that liraglutide should not be used in people with a family history of medullary thyroid cancer (4) A study showing there is no increase in the risk of thyroid cancer (for additional perspective) (5) A meta-analysis showing that there is not enough evidence to suggest there is a link between thyroid cancer and GLP-1 agonists (6) Its worth pointing out that while there is still debate on this topic, the larger and bigger studies on this issue seem to support a connection between the two

Mindfulness and acceptance-based interventions, such as mindfulness-based cognitive therapy, mindfulness-based stress reduction, and acceptance and commitment therapy, are therapeutic approaches to enhance psychological flexibility, awareness, and non-judgmental acceptance of present-moment experiences, including bodily sensations, thoughts, and feelings [220]